|
|
Post by lakon on Aug 29, 2021 10:14:10 GMT -5
If MNKD can stay above $5/sh, and then $10/sh, institutional ownership will grow from fund managers as well as analyst coverage. Add MNKD back into an index or two and away we go!
Reddit! Sure, why not?
UTHR Tyvaso DPI!
NRXP!
Clofazamine!
Partnerships!
RLS!
Afrezza!
With more cash to burn, the trajectory of Afrezza scripts could change dramatically too...
Becoming a household name due to COVID-19 treatment would be priceless!!!
|
|
|
|
Post by boca1girl on Aug 29, 2021 10:47:59 GMT -5
This is our plan. let's enjoy the ride. There are multiple things that could light a fuse for MNKD. Tyvaso approval brings revenue and that is very likely IMO. If Zyesami IV gets approved, that bodes well for development and approval of inhalable. Zyesami had the potential to allow us all to retire. Within the last 3 months MC said he was most excited about Clofazamine. Who knows why. MC mentioned EU submission for Afrezza. The only way that can work is if they have an EU partner. Add in RLS, undisclosed molecules, and any other surprises and this could get interesting. Time will tell. I have a bad taste in my mouth from being a shareholder for an embarrassing 9 years. Would like to finally get out of this one and invest elsewhere. Been here a long time too, but I would never consider bailing AFTER we made it to the big time. I love Peppy’s projections but the conservative in me would love to see $25 by the end of 2022. |
|
|
|
Post by prcgorman2 on Aug 29, 2021 10:55:40 GMT -5
If MNKD can stay above $5/sh, and then $10/sh, institutional ownership will grow from fund managers as well as analyst coverage. Add MNKD back into an index or two and away we go! Reddit! Sure, why not? UTHR Tyvaso DPI! NRXP! Clofazamine! Partnerships! RLS! Afrezza! With more cash to burn, the trajectory of Afrezza scripts could change dramatically too... Becoming a household name due to COVID-19 treatment would be priceless!!! Amen. The NRXP thing is particularly interesting to me. The idea of a better-than-remdesivir temperature-stable therapeutic for COVID-19 and other SARS infections that could be inhaled from a disposable whistle and shipped worldwide is extremely enticing. (Maybe they can create a little plastic flute that clicks onto the inhaler for a non-disposable child’s toy). Anyway, I bought some shares. :-) |
|
|
|
Post by churchmouse on Aug 29, 2021 12:26:06 GMT -5
Is your target dependent on the short side unwinding their position?
|
|
|
|
Post by peppy on Aug 29, 2021 12:29:23 GMT -5
Is your target dependent on the short side unwinding their position? not really. I am however wanting to see when Goldman Sacs arrives at the Quarterly Conference Calls. |
|
|
|
Post by goyocafe on Aug 29, 2021 14:26:32 GMT -5
Is your target dependent on the short side unwinding their position? not really. I am however wanting to see when Goldman Sacs arrives at the Quarterly Conference Calls. So I’m guessing you nibbled on NRXP, too? |
|
|
|
Post by peppy on Aug 29, 2021 14:56:26 GMT -5
not really. I am however wanting to see when Goldman Sacs arrives at the Quarterly Conference Calls. So I’m guessing you nibbled on NRXP, too? no, did you? Patten had a tweet up under Zyesami today. |
|
|
|
Post by goyocafe on Aug 29, 2021 15:06:01 GMT -5
So I’m guessing you nibbled on NRXP, too? no, did you? Patten had a tweet up under Zyesami today. I did. Multiple shots on goal there as well (Bipolar w/ suicide, Covid vaccine, and Zyesami), plus a healthy lending rate over at Fidelity. I’m still curious how the IP will play out on Zyesami-DPI. That will be huge for MNKD given that no matter the share between NRXP and RLFT, MNKD holds the dry powder process. I still wonder why MC hasn’t taken generic Aviptadil and put it in dry powder rather than Zyesami. They could own the whole enchilada. |
|
|
|
Post by cretin11 on Aug 29, 2021 16:37:09 GMT -5
That’s a good question.
By the way, what has the lending rate been lately on that?
|
|
|
|
Post by goyocafe on Aug 29, 2021 19:48:30 GMT -5
That’s a good question. By the way, what has the lending rate been lately on that? Currently paying 42.25% at Fidelity. I’ve read that the total loan rate is up to 196% at some brokerages and there are zero shares available to loan. |
|
|
|
Post by Thundersnow on Aug 29, 2021 21:36:36 GMT -5
no, did you? Patten had a tweet up under Zyesami today. I did. Multiple shots on goal there as well (Bipolar w/ suicide, Covid vaccine, and Zyesami), plus a healthy lending rate over at Fidelity. I’m still curious how the IP will play out on Zyesami-DPI. That will be huge for MNKD given that no matter the share between NRXP and RLFT, MNKD holds the dry powder process. I still wonder why MC hasn’t taken generic Aviptadil and put it in dry powder rather than Zyesami. They could own the whole enchilada. MNKD has a patent for VIP. Mike didn't have the cashflow to develop Aviptadil. |
|
|
|
Post by goyocafe on Aug 30, 2021 6:44:41 GMT -5
That’s a good question. By the way, what has the lending rate been lately on that? Currently paying 42.25% at Fidelity. I’ve read that the total loan rate is up to 196% at some brokerages and there are zero shares available to loan. Paid lending rate at Fidelity now 48.625 for Monday. |
|
|
|
Post by winner on Aug 30, 2021 7:14:52 GMT -5
Sitting here on my deck with my morning coffee. Looking forward to seeing how the day unfolds. I would love to see a close above $5.00 today. Time will tell. 39 business days to the 21st Oct. 2021....
|
|
|
|
Post by peppy on Aug 30, 2021 7:24:35 GMT -5
Sitting here on my deck with my morning coffee. Looking forward to seeing how the day unfolds. I would love to see a close above $5.00 today. Time will tell. 39 business days to the 21st Oct. 2021.... two more trading days ends the month. $5.50 last months high. @$5.30 is point of smaller triangle break out. Let's see. It would be nice to have a strong ending of the month and have price pull up out of the consolidation. One more thing. Perhaps what we have been witnessing price and volume wise is the slow turn. A repositioning so to speak. Everyone one on Wall Street knows what we have been typing about. Consider, Wall Street rode MNKD all the way down, the slow turn of repositioning, Wall Street is going to ride MNKD all the way up now. Oh please. |
|
|
|
Post by peppy on Aug 30, 2021 9:00:38 GMT -5
Volume on the half hour of trade. (Volume had been running 600,000 the first hour on a good days worth of volume.)
real time, 341,435
summary, 483,445
Avg. Volume 3,277,701
4.9435. +0.0335 (+0.6823%)
As of 10:00AM EDT. Market open.
NRXP had a press release this morning posted off topic.
added, volume at 1 hour of trade,
real time, 387,367
summary, 604,256
4.8533. -0.0567 (-1.1548%)
As of 10:31AM EDT. Market open.
|
|
